Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer

Medical Oncology

Volumn 31, Issue 8, 2014, Pages

  Qin, Hui ^a   Ni, Yijiang ^a   Tong, Jichun ^a   Zhao, Jiabi ^a   Zhou, Xiaoli ^a   Cai, Wei ^b   Liang, Jie ^a   Yao, Xin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

CRYAB; IHC; NSCLC; qPCR; Western blotting

Indexed keywords

ALPHA B CRYSTALLIN; ALPHA CRYSTALLIN; MESSENGER RNA; UNCLASSIFIED DRUG; CRYAB PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; WESTERN BLOTTING; AGED; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

AGED; ALPHA-CRYSTALLIN B CHAIN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904445945     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0142-1     Document Type: Article

References (33)

1. Fu M, Fan W, Pu X, et al. Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2013;6:2185-91.
2. Lv H, Han T, Shi X, et al. Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer. Med Oncol. 2014;31:86.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
4. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.
5. Li SJ, Wang WY, Li B, et al. Expression of NDRG2 in human lung cancer and its correlation with prognosis. Med Oncol. 2013;30:421.
6. Esposito L, Conti D, Ailavajhala R, et al. Lung cancer: are we up to the challenge? Curr Genomics. 2010;11:513-8.
7. Cai X, Sheng J, Tang C, et al. Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by Ion Torrent DNA sequencing. PLoS One. 2014;9:e95228.
8. Pirker R. Novel drugs against non-small-cell lung cancer. Curr Opin Oncol. 2014;26:145-51.
9. Lin L, Asthana S, Chan E, et al. Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer. Proc Natl Acad Sci USA. 2014;111:E748-57.
10. Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. 2014;106:djt356.
11. Kim HS, Lee Y, Lim YA, et al. aB-crystallin is a novel oncoprotein associated with poor prognosis in breast cancer. J Breast Cancer. 2011;14:14-9.
12. Liu S, Li J, Tao Y, et al. Small heat shock protein aB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem Biophys Res Commun. 2007;354:109-14. (Pubitemid 46123208)
13. Volkmann J, Reuning U, Rudelius M, et al. High expression of crystalline aB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells. Int J Cancer. 2013;132:2820-32.
14. Mao Y, Zhang DW, Lin H, et al. Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. J Exp Clin Cancer Res. 2012;31:101.
15. Malin D, Strekalova E, Petrovic V, et al. αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res. 2014;20:56-67.
16. Kase S, He S, Sonoda S, et al. alphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood. 2010;115:3398-406.
17. Chen P, Ji W, Liu FY, et al. Alpha-crystallins and tumorigenesis. Curr Mol Med. 2012;12:1164-73.
18. van de Schootbrugge C, Bussink J, Span PN, et al. αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma. BMC Cancer. 2013;13:128.
19. Annertz K, Enoksson J, Williams R, et al. Alpha B-crystallin - a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavity. Acta Otolaryngol. 2014;134:543-50.
20. Tang Q, Liu YF, Zhu XJ, et al. Expression and prognostic significance of the aB-crystallin gene in human hepatocellular carcinoma. Hum Pathol. 2009;40:300-5.
21. Chen R, Lu M, Wang J, et al. Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type. Virchows Arch. 2013;463:713-9.
22. Ni S, Xu L, Huang J, et al. Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2013;6:2887-95.
23. Andley UP. Crystallins in the eye: function and pathology. Prog Retin Eye Res. 2007;26:78-98. (Pubitemid 44894995)
24. Dimberg A, Rylova S, Dieterich LC, et al. alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood. 2008;111:2015-23. (Pubitemid 351451512)
25. Arrigo AP, Gibert B. HspB1, HspB5 and HspB4 in human cancers: potent oncogenic role of some of their client proteins. Cancers (Basel). 2014;6:333-65.
26. Petrovic V, Malin D, Cryns VL. aB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation. Breast Cancer Res Treat. 2013;138:415-25.
27. Chakraborty S, Adhikary A, Mazumdar M, et al. Capsaicin-induced activation of p53-SMAR1 auto-regulatory loop downregulates VEGF in non-small cell lung cancer to restrain angiogenesis. PLoS One. 2014;9:e99743.
28. Mai CW, Yaeghoobi M, Abd-Rahman N, et al. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins. Eur J Med Chem. 2014;77:378-87.
29. Ye Y, Wang D, Su C, et al. Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray. Genet Mol Res. 2009;8:1509-18.
30. Huang Z, Cheng Y, Chiu PM, et al. Tumor suppressor AlphaB-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene. 2012;31:3709-20.
31. Barbash O, Zamfirova P, Lin DI, et al. Mutations in Fbx4 inhibit dimerization of the SCF (Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell. 2008;14:68-78. (Pubitemid 351885497)
32. Boslooper K, King-Yin Lam A, Gao J, et al. The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma. Pathology. 2008;40:500-4. (Pubitemid 351950887)
33. Campbell-Lloyd AJ, Mundy J, Deva R, et al. Is alpha-B crystalline an independent marker for prognosis in lung cancer? Heart Lung Circ. 2013;22:759-66.